A carregar...
A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with Candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3
PURPOSE: Non-surgical treatments for cervical intraepithelial neoplasia 2/3 (CIN2/3) are needed as surgical treatments have been shown to double preterm delivery rate. The goal of this study was to demonstrate safety of a human papillomavirus (HPV) therapeutic vaccine called PepCan, which consists o...
Na minha lista:
Publicado no: | Oncoimmunology |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Taylor & Francis
2015
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4590015/ https://ncbi.nlm.nih.gov/pubmed/26451301 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1031439 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|